Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus.

Nigolian H, Ribi C, Courvoisier DS, Pagano S, Alvarez M, Trendelenburg M, Huynh-Do U, Vuilleumier N, Dayer JM, Chizzolini C, Roux-Lombard P.

Rheumatology (Oxford). 2019 Aug 3. pii: kez306. doi: 10.1093/rheumatology/kez306. [Epub ahead of print]

PMID:
31377780
2.

Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: a review of the literature.

Traineau H, Aggarwal R, Monfort JB, Senet P, Oddis CV, Chizzolini C, Barbaud A, Francès C, Arnaud L, Chasset F.

J Am Acad Dermatol. 2019 Jul 11. pii: S0190-9622(19)32318-7. doi: 10.1016/j.jaad.2019.07.006. [Epub ahead of print]

PMID:
31302187
3.

IL-17A Dissociates Inflammation from Fibrogenesis in Systemic Sclerosis.

Dufour AM, Borowczyk-Michalowska J, Alvarez M, Truchetet ME, Modarressi A, Brembilla NC, Chizzolini C.

J Invest Dermatol. 2019 Jul 3. pii: S0022-202X(19)31791-9. doi: 10.1016/j.jid.2019.05.026. [Epub ahead of print]

PMID:
31276679
4.

CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis.

Lande R, Lee EY, Palazzo R, Marinari B, Pietraforte I, Santos GS, Mattenberger Y, Spadaro F, Stefanantoni K, Iannace N, Dufour AM, Falchi M, Bianco M, Botti E, Bianchi L, Alvarez M, Riccieri V, Truchetet ME, C L Wong G, Chizzolini C, Frasca L.

Nat Commun. 2019 May 1;10(1):1731. doi: 10.1038/s41467-019-09683-z.

5.

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.

Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, Braun-Moscovici Y, Iannone F, Novikov PI, Lescoat A, Siegert E, Castellví I, Airó P, Vettori S, De Langhe E, Hachulla E, Erler A, Ananieva L, Krusche M, López-Longo FJ, Distler JHW, Hunzelmann N, Hoffmann-Vold AM, Riccieri V, Hsu VM, Pozzi MR, Ancuta C, Rosato E, Mihai C, Kuwana M, Saketkoo LA, Chizzolini C, Hesselstrand R, Ullman S, Yavuz S, Rednic S, Caimmi C, Bloch-Queyrat C, Allanore Y; for EUSTAR network.

Ann Rheum Dis. 2019 Jul;78(7):979-987. doi: 10.1136/annrheumdis-2018-214816. Epub 2019 Apr 9.

PMID:
30967395
6.

Quand penser à une myosite et quelle attitude adopter ?

Chizzolini C.

Rev Med Suisse. 2019 Jan 30;15(636):301-303. French. No abstract available.

PMID:
30724520
7.

Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre study.

Walker UA, Jaeger VK, Bruppacher KM, Dobrota R, Arlettaz L, Banyai M, Beron J, Chizzolini C, Groechenig E, Mueller RB, Spertini F, Villiger PM, Distler O.

Arthritis Res Ther. 2018 Oct 25;20(1):239. doi: 10.1186/s13075-018-1733-6.

8.

Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.

Nehring J, Schirmbeck LA, Friebus-Kardash J, Dubler D, Huynh-Do U, Chizzolini C, Ribi C, Trendelenburg M.

Front Immunol. 2018 Oct 2;9:2090. doi: 10.3389/fimmu.2018.02090. eCollection 2018.

9.

Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus.

Pröbstel AK, Thanei M, Erni B, Lecourt AC, Branco L, André R, Roux-Lombard P, Koenig KF, Huynh-Do U, Ribi C, Chizzolini C, Kappos L, Trendelenburg M, Derfuss T; Swiss Systemic Lupus Erythematosus Cohort Study Group.

Rheumatology (Oxford). 2019 May 1;58(5):908-913. doi: 10.1093/rheumatology/key282.

PMID:
30265368
10.

Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1.

Dufour AM, Alvarez M, Russo B, Chizzolini C.

Front Immunol. 2018 Aug 13;9:1865. doi: 10.3389/fimmu.2018.01865. eCollection 2018.

11.

Limbic encephalitis associated with systemic sclerosis.

De Stefano P, Chizzolini C, Lalive PH, Lascano AM.

Mult Scler Relat Disord. 2018 Aug;24:142-144. doi: 10.1016/j.msard.2018.06.019. Epub 2018 Jul 10.

PMID:
30005357
12.

Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus.

Marchetti T, Ribi C, Perneger T, Trendelenburg M, Huynh-Do U, de Moerloose P, Chizzolini C.

Rheumatology (Oxford). 2018 Aug 1;57(8):1350-1357. doi: 10.1093/rheumatology/key095.

PMID:
29672737
13.

Chagas disease and systemic autoimmune diseases among Bolivian patients in Switzerland.

Jackson Y, Pula DVM, Finckh A, Chizzolini C, Chappuis F.

Mem Inst Oswaldo Cruz. 2018 Feb 5;113(4):e170383. doi: 10.1590/0074-02760170383.

14.

Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.

Dahdal S, Devetzis V, Chalikias G, Tziakas D, Chizzolini C, Ribi C, Trendelenburg M, Eisenberger U, Hauser T, Pasch A, Huynh-Do U, Arampatzis S; Swiss Systemic Lupus Erythematosus Cohort Study Group.

PLoS One. 2018 Jan 24;13(1):e0188695. doi: 10.1371/journal.pone.0188695. eCollection 2018.

15.

[Allergology and clinical immunology].

Coattrenec Y, Harr T, Chizzolini C, Jandus P.

Rev Med Suisse. 2018 Jan 10;14(588-589):15-18. French.

PMID:
29337441
16.

Case Report: Masquerading Large-vessel Giant Cell Arteritis.

Jacquier P, Wuarin R, Chizzolini C, Thumann G, Steffen H, Chronopoulos A.

Optom Vis Sci. 2017 Dec;94(12):1159-1164. doi: 10.1097/OPX.0000000000001151.

PMID:
29120976
17.

Prevalence and Disease-Specific Risk Factors for Lower Urinary Tract Symptoms in Systemic Sclerosis: An International Multicenter Study.

John G, Avouac J, Piantoni S, Polito P, Fredi M, Cozzi F, Airò P, Truchetet ME, Franceschini F, Allanore Y, Chizzolini C.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1218-1227. doi: 10.1002/acr.23454. Epub 2018 Jun 19.

18.

Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus.

Friebus-Kardash J, Branco L, Ribi C, Chizzolini C, Huynh-Do U, Dubler D, Roux-Lombard P, Dolff S, Kribben A, Eisenberger U, Trendelenburg M.

Nephrol Dial Transplant. 2018 Jan 1;33(1):54-64. doi: 10.1093/ndt/gfx220.

PMID:
28992184
19.

The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study.

John G, Allanore Y, Polito P, Piantoni S, Fredi M, Avouac J, Franceschini F, Truchetet ME, Cozzi F, Airo P, Chizzolini C.

Rheumatology (Oxford). 2017 Nov 1;56(11):1874-1883. doi: 10.1093/rheumatology/kex230.

PMID:
28977630
20.

Is there a role for IL-17 in the pathogenesis of systemic sclerosis?

Chizzolini C, Dufour AM, Brembilla NC.

Immunol Lett. 2018 Mar;195:61-67. doi: 10.1016/j.imlet.2017.09.007. Epub 2017 Sep 15. Review.

PMID:
28919455
21.

Mapping and predicting mortality from systemic sclerosis.

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y; EUSTAR group.

Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.

PMID:
28835464
22.

Mesenteric inflammatory veno-occlusive disease of the spleen metasynchronous with two arterial thrombotic events in systemic lupus erythematosus.

Allali D, Puppa G, Chizzolini C.

Lupus. 2018 Jan;27(1):150-153. doi: 10.1177/0961203317700980. Epub 2017 Mar 29.

PMID:
28355983
23.

Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).

Chaigne B, Chizzolini C, Perneger T, Trendelenburg M, Huynh-Do U, Dayer E, Stoll T, von Kempis J, Ribi C; Swiss Systemic Lupus Erythematosus Cohort Study Group.

BMC Immunol. 2017 Mar 28;18(1):17. doi: 10.1186/s12865-017-0200-5.

24.

Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life.

Chaigne B, Finckh A, Alpizar-Rodriguez D, Courvoisier D, Ribi C, Chizzolini C; Swiss Clinical Quality Management Program For Rheumatoid Arthritis; Swiss Systemic Lupus Erythematosus Cohort Study Group.

Qual Life Res. 2017 Jul;26(7):1767-1775. doi: 10.1007/s11136-017-1534-4. Epub 2017 Mar 11.

PMID:
28285445
25.

Keratinocyte-Derived IL-17E Contributes to Inflammation in Psoriasis.

Senra L, Stalder R, Alvarez Martinez D, Chizzolini C, Boehncke WH, Brembilla NC.

J Invest Dermatol. 2016 Oct;136(10):1970-1980. doi: 10.1016/j.jid.2016.06.009. Epub 2016 Jun 18.

26.

Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumab.

Simonetta F, Allali D, Roux-Lombard P, Chizzolini C.

Joint Bone Spine. 2017 Mar;84(2):235-236. doi: 10.1016/j.jbspin.2016.01.008. Epub 2016 May 26. No abstract available.

PMID:
27238199
27.

A 28-Year-Old Man Presenting With Intractable Dry Cough and a History of Ulcerative Colitis.

Lücker LM, Hachulla AL, Lador F, Chizzolini C, Adler D.

Chest. 2016 May;149(5):e141-5. doi: 10.1016/j.chest.2015.12.011.

PMID:
27157229
28.

IL-22 capacitates dermal fibroblast responses to TNF in scleroderma.

Brembilla NC, Dufour AM, Alvarez M, Hugues S, Montanari E, Truchetet ME, Lonati P, Fontao L, Gabrielli A, Vettori S, Valentini G, Boehncke WH, Meroni P, Chizzolini C.

Ann Rheum Dis. 2016 Sep;75(9):1697-705. doi: 10.1136/annrheumdis-2015-207477. Epub 2015 Oct 9.

PMID:
26452537
29.

Diagnostic Dilemma in Sequential Branch Retinal Vein and Artery Occlusion.

Consigli A, Roquelaure D, Souteyrand G, Chizzolini C, Thumann G, Chronopoulos A.

Optom Vis Sci. 2015 Nov;92(11):e404-8. doi: 10.1097/OPX.0000000000000707.

PMID:
26421682
30.

The role of the acquired immune response in systemic sclerosis.

Chizzolini C, Boin F.

Semin Immunopathol. 2015 Sep;37(5):519-28. doi: 10.1007/s00281-015-0509-1. Epub 2015 Jul 8. Review.

PMID:
26152639
31.

[Lung involvement in systemic sclerosis].

Posa M, Stelle M, Lador F, Chizzolini C.

Rev Med Suisse. 2015 Apr 8;11(469):802-6. French.

PMID:
26040160
32.

Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab.

Simonetta F, Posa M, Villard J, Marceau-Renaut A, Preudhomme C, Samii K, Chizzolini C.

Ann Hematol. 2015 Jul;94(7):1247-9. doi: 10.1007/s00277-015-2363-6. Epub 2015 Apr 7. No abstract available.

PMID:
25847363
33.

High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.

Lonati PA, Brembilla NC, Montanari E, Fontao L, Gabrielli A, Vettori S, Valentini G, Laffitte E, Kaya G, Meroni PL, Chizzolini C.

PLoS One. 2014 Aug 19;9(8):e105008. doi: 10.1371/journal.pone.0105008. eCollection 2014.

34.

The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.

Ribi C, Trendelenburg M, Gayet-Ageron A, Cohen C, Dayer E, Eisenberger U, Hauser T, Hunziker T, Leimgruber A, Lindner G, Koenig K, Otto P, Spertini F, Stoll T, Von Kempis J, Chizzolini C; Swiss Systemic Lupus Erythematosus Cohort Study Group.

Swiss Med Wkly. 2014 Aug 7;144:w13990. doi: 10.4414/smw.2014.13990. eCollection 2014.

35.

[Gastrointestinal features in systemic sclerosis].

Stelle M, Chizzolini C.

Rev Med Suisse. 2014 Apr 16;10(426):860-3. French.

PMID:
24834644
36.

[Systemic vasculitides: novel nomenclature and novel therapeutic approaches].

Allali D, Chizzolini C.

Rev Med Suisse. 2014 Apr 16;10(426):854-8. French.

PMID:
24834643
37.

[Renal disease in ANCA-associated vasculitis].

Fumeaux D, de Seigneux S, Chizzolini C, Martin PY.

Rev Med Suisse. 2014 Feb 26;10(419):493-7. Review. French.

PMID:
24665659
38.

Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.

Brembilla NC, Montanari E, Truchetet ME, Raschi E, Meroni P, Chizzolini C.

Arthritis Res Ther. 2013 Oct 10;15(5):R151. doi: 10.1186/ar4334.

39.

Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis.

Duxbury B, Combescure C, Chizzolini C.

Lupus. 2013 Dec;22(14):1489-503. doi: 10.1177/0961203313509295. Epub 2013 Oct 17. Review.

PMID:
24135078
40.

[Dysimmune neuromuscular disorders: diagnostic challenges and new ways of management].

Lalive PH, Du Pasquier RA, Chizzolini C, Kuntzer T.

Rev Med Suisse. 2013 May 1;9(384):934-9. Review. French.

PMID:
23717903
41.

Response of mucocutaneous lesions to rituximab in a case of melanoma differentiation antigen 5-related dermatomyositis.

Clottu A, Laffitte E, Prins C, Chizzolini C.

Dermatology. 2012;225(4):376-80. doi: 10.1159/000346573. Epub 2013 Feb 15.

42.

T cell abnormalities in systemic sclerosis with a focus on Th17 cells.

Brembilla NC, Chizzolini C.

Eur Cytokine Netw. 2012 Oct-Dec;23(4):128-39. doi: 10.1684/ecn.2013.0325. Review.

43.

Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement.

Truchetet ME, Brembilla NC, Montanari E, Lonati P, Raschi E, Zeni S, Fontao L, Meroni PL, Chizzolini C.

Arthritis Rheum. 2013 May;65(5):1347-56. doi: 10.1002/art.37860.

44.

Acquired factor XIII deficiency: a therapeutic challenge.

Boehlen F, Casini A, Chizzolini C, Mansouri B, Kohler HP, Schroeder V, Reber G, de Moerloose P.

Thromb Haemost. 2013 Mar;109(3):479-87. doi: 10.1160/TH12-08-0604. Epub 2013 Jan 10. Review.

PMID:
23306660
45.

Acute natural killer cell pneumonia in a patient transplanted with autologous haematopoietic stem cells for systemic sclerosis.

Chizzolini C, Vukicevic M, Rochat T, Tyndall A, Roosnek E.

Rheumatology (Oxford). 2013 May;52(5):954-6. doi: 10.1093/rheumatology/kes276. Epub 2012 Oct 26. No abstract available.

PMID:
23104981
46.

Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosis.

Truchetet ME, Allanore Y, Montanari E, Chizzolini C, Brembilla NC.

Ann Rheum Dis. 2012 Dec;71(12):2044-50. doi: 10.1136/annrheumdis-2012-201400. Epub 2012 Jul 19.

PMID:
22814427
47.

Cardiac involvement in Churg-Strauss syndrome mimicking acute coronary syndrome.

Rigamonti F, De Benedetti E, Letovanec I, Rosset A, Chizzolini C.

Swiss Med Wkly. 2012 Mar 19;142:w13543. doi: 10.4414/smw.2012.13543. eCollection 2012.

48.

[Allergo-immunology. Clinical immunology].

Chizzolini C.

Rev Med Suisse. 2012 Jan 11;8(323):11-3. French.

PMID:
22303732
49.

Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease.

Truchetet ME, Brembilla NC, Montanari E, Allanore Y, Chizzolini C.

Arthritis Res Ther. 2011;13(5):R166. doi: 10.1186/ar3486. Epub 2011 Oct 13.

50.

Hypereosinophilia in patients with multiple sclerosis treated with natalizumab.

Abbas M, Lalive PH, Chofflon M, Simon HU, Chizzolini C, Ribi C.

Neurology. 2011 Oct 18;77(16):1561-4. doi: 10.1212/WNL.0b013e318233b391. Epub 2011 Oct 5.

PMID:
21975205

Supplemental Content

Loading ...
Support Center